

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.91607087 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.61284681 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.22222016 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.18778563 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.16021746 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.98853934 |
| 7 | glutamate secretion (GO:0014047) | 4.94735531 |
| 8 | vocalization behavior (GO:0071625) | 4.85861496 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.78296820 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.72554921 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.48490180 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.47716653 |
| 13 | protein localization to synapse (GO:0035418) | 4.42852539 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.33476117 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.29917456 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.24071310 |
| 17 | exploration behavior (GO:0035640) | 4.19918953 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.12363217 |
| 19 | layer formation in cerebral cortex (GO:0021819) | 4.06208599 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.02811279 |
| 21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.00067050 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.98952337 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 3.96931144 |
| 24 | neuronal action potential propagation (GO:0019227) | 3.95870596 |
| 25 | cellular potassium ion homeostasis (GO:0030007) | 3.93417439 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 3.85682267 |
| 27 | neuron recognition (GO:0008038) | 3.82449769 |
| 28 | proline transport (GO:0015824) | 3.80107641 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 3.78288017 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.66630887 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.64562818 |
| 32 | synaptic vesicle endocytosis (GO:0048488) | 3.61499995 |
| 33 | dendritic spine morphogenesis (GO:0060997) | 3.61077909 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 3.60007128 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.56976031 |
| 36 | activation of protein kinase A activity (GO:0034199) | 3.54710857 |
| 37 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.53477567 |
| 38 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.50678040 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.49660953 |
| 40 | sodium ion export (GO:0071436) | 3.49140169 |
| 41 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.41022635 |
| 42 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.41022635 |
| 43 | long-term memory (GO:0007616) | 3.38856909 |
| 44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.38072819 |
| 45 | vesicle transport along microtubule (GO:0047496) | 3.37853074 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.37586003 |
| 47 | neurotransmitter transport (GO:0006836) | 3.37315092 |
| 48 | axonal fasciculation (GO:0007413) | 3.36973483 |
| 49 | positive regulation of synapse maturation (GO:0090129) | 3.36264249 |
| 50 | dendrite morphogenesis (GO:0048813) | 3.31982255 |
| 51 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.30080462 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.29171299 |
| 53 | regulation of synaptic plasticity (GO:0048167) | 3.28182128 |
| 54 | response to pheromone (GO:0019236) | 3.24601060 |
| 55 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.23506867 |
| 56 | regulation of ARF protein signal transduction (GO:0032012) | 3.20824258 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.20450389 |
| 58 | neuromuscular process controlling balance (GO:0050885) | 3.20123830 |
| 59 | membrane depolarization during action potential (GO:0086010) | 3.19702265 |
| 60 | negative regulation of interleukin-17 production (GO:0032700) | 3.18835792 |
| 61 | long-term synaptic potentiation (GO:0060291) | 3.17374779 |
| 62 | innervation (GO:0060384) | 3.17078432 |
| 63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.15938229 |
| 64 | neuromuscular process controlling posture (GO:0050884) | 3.15466562 |
| 65 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.14357584 |
| 66 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.14130460 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.11916053 |
| 68 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.11529261 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.09719157 |
| 70 | transmission of nerve impulse (GO:0019226) | 3.05721033 |
| 71 | cell communication by electrical coupling (GO:0010644) | 3.05423012 |
| 72 | organelle transport along microtubule (GO:0072384) | 3.05323266 |
| 73 | negative regulation of neurotransmitter transport (GO:0051589) | 3.04466172 |
| 74 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.04102307 |
| 75 | nerve growth factor signaling pathway (GO:0038180) | 3.03969649 |
| 76 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.02402375 |
| 77 | regulation of vesicle fusion (GO:0031338) | 3.00965020 |
| 78 | response to auditory stimulus (GO:0010996) | 3.00113235 |
| 79 | potassium ion import (GO:0010107) | 2.98795265 |
| 80 | membrane depolarization (GO:0051899) | 2.98683017 |
| 81 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.95761062 |
| 82 | membrane hyperpolarization (GO:0060081) | 2.95461601 |
| 83 | retinal cone cell development (GO:0046549) | 2.95040425 |
| 84 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.93357614 |
| 85 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.92746372 |
| 86 | glycine transport (GO:0015816) | 2.91929302 |
| 87 | regulation of neurotransmitter transport (GO:0051588) | 2.91553898 |
| 88 | mating behavior (GO:0007617) | 2.91485687 |
| 89 | behavioral fear response (GO:0001662) | 2.90512178 |
| 90 | behavioral defense response (GO:0002209) | 2.90512178 |
| 91 | neurotransmitter uptake (GO:0001504) | 2.88762486 |
| 92 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.87635643 |
| 93 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.86889000 |
| 94 | L-amino acid import (GO:0043092) | 2.85966402 |
| 95 | prepulse inhibition (GO:0060134) | 2.85151805 |
| 96 | synapse assembly (GO:0007416) | 2.85108354 |
| 97 | cell migration in hindbrain (GO:0021535) | 2.84702286 |
| 98 | response to histamine (GO:0034776) | 2.84459361 |
| 99 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.84162547 |
| 100 | auditory behavior (GO:0031223) | 2.82485069 |
| 101 | neuromuscular process (GO:0050905) | 2.81813839 |
| 102 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.81762031 |
| 103 | detection of calcium ion (GO:0005513) | 2.81131516 |
| 104 | learning (GO:0007612) | 2.80369250 |
| 105 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79760884 |
| 106 | cellular response to ethanol (GO:0071361) | 2.79679140 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.78542887 |
| 108 | regulation of dendritic spine development (GO:0060998) | 2.77806013 |
| 109 | positive regulation of synaptic transmission (GO:0050806) | 2.77267235 |
| 110 | postsynaptic membrane organization (GO:0001941) | 2.77135359 |
| 111 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.77135132 |
| 112 | intraspecies interaction between organisms (GO:0051703) | 2.76468257 |
| 113 | social behavior (GO:0035176) | 2.76468257 |
| 114 | Golgi to endosome transport (GO:0006895) | 2.76142242 |
| 115 | fear response (GO:0042596) | 2.75108426 |
| 116 | regulation of synaptic transmission (GO:0050804) | 2.75084958 |
| 117 | positive regulation of phosphatase activity (GO:0010922) | 2.74439984 |
| 118 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.74436614 |
| 119 | neuronal ion channel clustering (GO:0045161) | 2.70696729 |
| 120 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.69653674 |
| 121 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.68594763 |
| 122 | cerebellar granule cell differentiation (GO:0021707) | 2.67346959 |
| 123 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.65156419 |
| 124 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.64938868 |
| 125 | adult walking behavior (GO:0007628) | 2.61627922 |
| 126 | regulation of cell communication by electrical coupling (GO:0010649) | 2.61394292 |
| 127 | cell differentiation in hindbrain (GO:0021533) | 2.59500412 |
| 128 | startle response (GO:0001964) | 2.58353575 |
| 129 | presynaptic membrane assembly (GO:0097105) | 2.58334123 |
| 130 | amino acid import (GO:0043090) | 2.57979246 |
| 131 | presynaptic membrane organization (GO:0097090) | 2.57483143 |
| 132 | central nervous system myelination (GO:0022010) | 2.56157590 |
| 133 | axon ensheathment in central nervous system (GO:0032291) | 2.56157590 |
| 134 | glycosphingolipid biosynthetic process (GO:0006688) | 2.55594474 |
| 135 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.50452232 |
| 136 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.47539390 |
| 137 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.45983605 |
| 138 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.41446722 |
| 139 | synaptic transmission (GO:0007268) | 2.41275844 |
| 140 | establishment of protein localization to Golgi (GO:0072600) | 2.40866287 |
| 141 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.40228042 |
| 142 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.39947673 |
| 143 | potassium ion homeostasis (GO:0055075) | 2.39402840 |
| 144 | calcium ion-dependent exocytosis (GO:0017156) | 2.38583034 |
| 145 | vesicle docking involved in exocytosis (GO:0006904) | 2.36548830 |
| 146 | regulation of exocytosis (GO:0017157) | 2.34645862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.66654457 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.63521766 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89602145 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.84244609 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.75148174 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.67537948 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.48869306 |
| 8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.47040536 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46807473 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46807473 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38371958 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37262662 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36986596 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.33325089 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.27415359 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23430208 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.21782073 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.19317728 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14013581 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.04312413 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02524538 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98893395 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.96304693 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96232484 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.94545985 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.94220050 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.89934370 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.83652436 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83222168 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81888122 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.81773416 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78608116 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.76515227 |
| 34 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73167467 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70071399 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66943604 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66874348 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60486836 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.57945882 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53851902 |
| 41 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.51892996 |
| 42 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.48526059 |
| 43 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.44955833 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.44174431 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44062956 |
| 46 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39680160 |
| 47 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.39680160 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.39324179 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38488759 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38180205 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37435964 |
| 52 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37002210 |
| 53 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.36778951 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35710357 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33579856 |
| 56 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29905240 |
| 57 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.28575042 |
| 58 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27528664 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27384997 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.26984685 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.26984685 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26873787 |
| 63 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.26823082 |
| 64 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26442905 |
| 65 | AR_19668381_ChIP-Seq_PC3_Human | 1.26287834 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25920882 |
| 67 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25785303 |
| 68 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24714339 |
| 69 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24207685 |
| 70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24071038 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23190510 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22042676 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21187916 |
| 74 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21052546 |
| 75 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20596849 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20423542 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20020814 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19278347 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19072140 |
| 80 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19065803 |
| 81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18325595 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17869117 |
| 83 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.17531801 |
| 84 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17238027 |
| 85 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17113361 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17048630 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16778190 |
| 88 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.16272421 |
| 89 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15487195 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.14974228 |
| 91 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14553939 |
| 92 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.13959956 |
| 93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13203770 |
| 94 | KDM2B_26808549_Chip-Seq_REH_Human | 1.12573702 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11609590 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10456466 |
| 97 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.10349254 |
| 98 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.10104596 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09084288 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08683000 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08574820 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07876813 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07529735 |
| 104 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07119291 |
| 105 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05520590 |
| 106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05286270 |
| 107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05266667 |
| 108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05196469 |
| 109 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04113726 |
| 110 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.04092759 |
| 111 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03609617 |
| 112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02876115 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02193517 |
| 114 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01925141 |
| 115 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01276743 |
| 116 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00810934 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98820563 |
| 118 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98267758 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97974010 |
| 120 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97633242 |
| 121 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97181729 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97136340 |
| 123 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97040232 |
| 124 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97015202 |
| 125 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96877526 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95817722 |
| 127 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93713455 |
| 128 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93684625 |
| 129 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93621511 |
| 130 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93596236 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91821541 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91256057 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90887976 |
| 134 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90839331 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90792885 |
| 136 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90201989 |
| 137 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89539314 |
| 138 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88141623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.27836484 |
| 2 | MP0003880_abnormal_central_pattern | 4.76271669 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.02125186 |
| 4 | MP0004270_analgesia | 3.82673033 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.26350559 |
| 6 | MP0009745_abnormal_behavioral_response | 3.19101068 |
| 7 | MP0002064_seizures | 3.08743466 |
| 8 | MP0009046_muscle_twitch | 3.06986973 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.87046725 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.68204589 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.67410494 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.60204101 |
| 13 | MP0002272_abnormal_nervous_system | 2.47418874 |
| 14 | MP0001486_abnormal_startle_reflex | 2.37873571 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.34266329 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.26858200 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.22949595 |
| 18 | MP0002822_catalepsy | 2.20945555 |
| 19 | MP0002736_abnormal_nociception_after | 2.11483023 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.07745938 |
| 21 | MP0000778_abnormal_nervous_system | 2.06573051 |
| 22 | MP0002909_abnormal_adrenal_gland | 2.04657400 |
| 23 | MP0003329_amyloid_beta_deposits | 2.04333788 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.02712941 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.02634755 |
| 26 | MP0008057_abnormal_DNA_replication | 1.95985718 |
| 27 | MP0004811_abnormal_neuron_physiology | 1.95977885 |
| 28 | MP0004858_abnormal_nervous_system | 1.94119817 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.93297134 |
| 30 | MP0001970_abnormal_pain_threshold | 1.93174240 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.92552276 |
| 32 | MP0002184_abnormal_innervation | 1.89466245 |
| 33 | MP0001984_abnormal_olfaction | 1.81959103 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.79197916 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.79085621 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.77200144 |
| 37 | MP0008569_lethality_at_weaning | 1.74123660 |
| 38 | MP0004924_abnormal_behavior | 1.71136127 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.71136127 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.70920720 |
| 41 | MP0000955_abnormal_spinal_cord | 1.67321193 |
| 42 | MP0003879_abnormal_hair_cell | 1.50597995 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.50532266 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.49154241 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.47640757 |
| 46 | MP0003633_abnormal_nervous_system | 1.43862271 |
| 47 | MP0003122_maternal_imprinting | 1.41324087 |
| 48 | MP0002066_abnormal_motor_capabilities/c | 1.40737469 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.30905256 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.30329904 |
| 51 | MP0003787_abnormal_imprinting | 1.26854508 |
| 52 | MP0003631_nervous_system_phenotype | 1.22633423 |
| 53 | MP0004885_abnormal_endolymph | 1.19129897 |
| 54 | MP0001529_abnormal_vocalization | 1.17571310 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.17307082 |
| 56 | MP0000604_amyloidosis | 1.16982355 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.14926600 |
| 58 | MP0001873_stomach_inflammation | 1.14597970 |
| 59 | MP0002229_neurodegeneration | 1.14524353 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.14295580 |
| 61 | MP0002152_abnormal_brain_morphology | 1.13623557 |
| 62 | MP0005671_abnormal_response_to | 1.11072002 |
| 63 | MP0005310_abnormal_salivary_gland | 1.10150594 |
| 64 | MP0004147_increased_porphyrin_level | 1.07916987 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.07586104 |
| 66 | MP0004142_abnormal_muscle_tone | 1.06608586 |
| 67 | MP0003634_abnormal_glial_cell | 1.05886497 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.04703363 |
| 69 | MP0003690_abnormal_glial_cell | 1.04601361 |
| 70 | MP0001905_abnormal_dopamine_level | 1.03183977 |
| 71 | MP0000751_myopathy | 1.01834071 |
| 72 | MP0005499_abnormal_olfactory_system | 1.00431748 |
| 73 | MP0005394_taste/olfaction_phenotype | 1.00431748 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.00012902 |
| 75 | MP0008961_abnormal_basal_metabolism | 0.99663652 |
| 76 | MP0000427_abnormal_hair_cycle | 0.98890480 |
| 77 | MP0000013_abnormal_adipose_tissue | 0.98851189 |
| 78 | MP0004043_abnormal_pH_regulation | 0.97461206 |
| 79 | MP0002069_abnormal_eating/drinking_beha | 0.97343732 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.96618361 |
| 81 | MP0001485_abnormal_pinna_reflex | 0.95552285 |
| 82 | MP0003045_fibrosis | 0.94265734 |
| 83 | MP0003121_genomic_imprinting | 0.94180854 |
| 84 | MP0003632_abnormal_nervous_system | 0.93450887 |
| 85 | MP0002090_abnormal_vision | 0.90976886 |
| 86 | MP0003283_abnormal_digestive_organ | 0.90788434 |
| 87 | MP0003890_abnormal_embryonic-extraembry | 0.90579137 |
| 88 | MP0004484_altered_response_of | 0.90277201 |
| 89 | MP0000920_abnormal_myelination | 0.88641816 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.87673545 |
| 91 | MP0005535_abnormal_body_temperature | 0.86655533 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.85376902 |
| 93 | MP0001958_emphysema | 0.85274701 |
| 94 | MP0005253_abnormal_eye_physiology | 0.84344581 |
| 95 | MP0004742_abnormal_vestibular_system | 0.83006008 |
| 96 | MP0008874_decreased_physiological_sensi | 0.82884908 |
| 97 | MP0004085_abnormal_heartbeat | 0.81758577 |
| 98 | MP0003195_calcinosis | 0.81166581 |
| 99 | MP0004233_abnormal_muscle_weight | 0.80405584 |
| 100 | MP0010307_abnormal_tumor_latency | 0.80273631 |
| 101 | MP0002752_abnormal_somatic_nervous | 0.77014542 |
| 102 | MP0004130_abnormal_muscle_cell | 0.76658374 |
| 103 | MP0001177_atelectasis | 0.74945713 |
| 104 | MP0004134_abnormal_chest_morphology | 0.73221783 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.72497792 |
| 106 | MP0008872_abnormal_physiological_respon | 0.70715726 |
| 107 | MP0001963_abnormal_hearing_physiology | 0.70082352 |
| 108 | MP0004510_myositis | 0.69561308 |
| 109 | MP0000631_abnormal_neuroendocrine_gland | 0.68554205 |
| 110 | MP0001299_abnormal_eye_distance/ | 0.66205400 |
| 111 | MP0005187_abnormal_penis_morphology | 0.64729738 |
| 112 | MP0002102_abnormal_ear_morphology | 0.64534132 |
| 113 | MP0003075_altered_response_to | 0.64265021 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.62123110 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.61626226 |
| 116 | MP0003868_abnormal_feces_composition | 0.59747843 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 0.58768711 |
| 118 | MP0001188_hyperpigmentation | 0.58410734 |
| 119 | MP0001943_abnormal_respiration | 0.57853220 |
| 120 | MP0003861_abnormal_nervous_system | 0.56905799 |
| 121 | MP0000747_muscle_weakness | 0.55865854 |
| 122 | MP0001664_abnormal_digestion | 0.52374443 |
| 123 | MP0010769_abnormal_survival | 0.51517483 |
| 124 | MP0005409_darkened_coat_color | 0.51298740 |
| 125 | MP0010770_preweaning_lethality | 0.50796072 |
| 126 | MP0002082_postnatal_lethality | 0.50796072 |
| 127 | MP0002876_abnormal_thyroid_physiology | 0.50465768 |
| 128 | MP0003956_abnormal_body_size | 0.49933091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.54822088 |
| 2 | Myokymia (HP:0002411) | 5.85381134 |
| 3 | Focal seizures (HP:0007359) | 5.45988624 |
| 4 | Visual hallucinations (HP:0002367) | 4.99898928 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.42739488 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 4.17914226 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.12449531 |
| 8 | Atonic seizures (HP:0010819) | 4.10240706 |
| 9 | Absence seizures (HP:0002121) | 4.04969776 |
| 10 | Febrile seizures (HP:0002373) | 3.99231820 |
| 11 | Action tremor (HP:0002345) | 3.89018616 |
| 12 | Dialeptic seizures (HP:0011146) | 3.76252390 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.70424855 |
| 14 | Ankle clonus (HP:0011448) | 3.57749748 |
| 15 | Truncal ataxia (HP:0002078) | 3.38672833 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.34384535 |
| 17 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.28098393 |
| 18 | Depression (HP:0000716) | 3.17490245 |
| 19 | Mutism (HP:0002300) | 3.17082099 |
| 20 | Postural instability (HP:0002172) | 3.13055243 |
| 21 | Drooling (HP:0002307) | 3.10839376 |
| 22 | Excessive salivation (HP:0003781) | 3.10839376 |
| 23 | Poor eye contact (HP:0000817) | 3.10557569 |
| 24 | Hyperventilation (HP:0002883) | 3.05863475 |
| 25 | Broad-based gait (HP:0002136) | 3.03296639 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.03286705 |
| 27 | Dysdiadochokinesis (HP:0002075) | 2.99664789 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 2.96123763 |
| 29 | Abnormal social behavior (HP:0012433) | 2.95969956 |
| 30 | Impaired social interactions (HP:0000735) | 2.95969956 |
| 31 | Neurofibrillary tangles (HP:0002185) | 2.94275835 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.93032351 |
| 33 | Fair hair (HP:0002286) | 2.92282509 |
| 34 | Dysmetria (HP:0001310) | 2.87804179 |
| 35 | Urinary urgency (HP:0000012) | 2.87593003 |
| 36 | Insidious onset (HP:0003587) | 2.85151402 |
| 37 | Termporal pattern (HP:0011008) | 2.85151402 |
| 38 | Papilledema (HP:0001085) | 2.81409209 |
| 39 | Spastic gait (HP:0002064) | 2.80990016 |
| 40 | Anxiety (HP:0000739) | 2.76778402 |
| 41 | Amblyopia (HP:0000646) | 2.74580142 |
| 42 | Epileptiform EEG discharges (HP:0011182) | 2.73253334 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.72261896 |
| 44 | Abnormality of the corticospinal tract (HP:0002492) | 2.68267628 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.65694354 |
| 46 | EEG with generalized epileptiform discharges (HP:0011198) | 2.65485887 |
| 47 | Papillary thyroid carcinoma (HP:0002895) | 2.63626966 |
| 48 | Genetic anticipation (HP:0003743) | 2.62531446 |
| 49 | Pheochromocytoma (HP:0002666) | 2.59662550 |
| 50 | Polyphagia (HP:0002591) | 2.57204715 |
| 51 | Generalized hypopigmentation of hair (HP:0011358) | 2.56907646 |
| 52 | Agitation (HP:0000713) | 2.53930648 |
| 53 | Hemiparesis (HP:0001269) | 2.52014242 |
| 54 | Widely spaced teeth (HP:0000687) | 2.51130904 |
| 55 | Progressive inability to walk (HP:0002505) | 2.51053328 |
| 56 | Torticollis (HP:0000473) | 2.49647916 |
| 57 | Hypsarrhythmia (HP:0002521) | 2.48826140 |
| 58 | Bradykinesia (HP:0002067) | 2.47169794 |
| 59 | Absent speech (HP:0001344) | 2.43263404 |
| 60 | Scanning speech (HP:0002168) | 2.42285772 |
| 61 | Lower limb muscle weakness (HP:0007340) | 2.41873501 |
| 62 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.38926137 |
| 63 | Intention tremor (HP:0002080) | 2.29133465 |
| 64 | Dysmetric saccades (HP:0000641) | 2.29105487 |
| 65 | Impaired vibratory sensation (HP:0002495) | 2.28961265 |
| 66 | Amyotrophic lateral sclerosis (HP:0007354) | 2.28386358 |
| 67 | Diplopia (HP:0000651) | 2.26931816 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.26931816 |
| 69 | Focal dystonia (HP:0004373) | 2.25949024 |
| 70 | Abnormal hair whorl (HP:0010721) | 2.23152420 |
| 71 | Hemiplegia (HP:0002301) | 2.21469123 |
| 72 | Neuronal loss in central nervous system (HP:0002529) | 2.21379095 |
| 73 | Neuroendocrine neoplasm (HP:0100634) | 2.17710803 |
| 74 | Blue irides (HP:0000635) | 2.15864358 |
| 75 | Stereotypic behavior (HP:0000733) | 2.15817305 |
| 76 | Limb dystonia (HP:0002451) | 2.15452228 |
| 77 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.14913983 |
| 78 | Status epilepticus (HP:0002133) | 2.13363239 |
| 79 | Failure to thrive in infancy (HP:0001531) | 2.13117473 |
| 80 | Inappropriate behavior (HP:0000719) | 2.11945225 |
| 81 | T lymphocytopenia (HP:0005403) | 2.10021673 |
| 82 | Inability to walk (HP:0002540) | 2.09760154 |
| 83 | Generalized myoclonic seizures (HP:0002123) | 2.09407708 |
| 84 | Clonus (HP:0002169) | 2.02727331 |
| 85 | Craniofacial dystonia (HP:0012179) | 2.01564070 |
| 86 | Megalencephaly (HP:0001355) | 2.01544813 |
| 87 | Abnormality of salivation (HP:0100755) | 2.01437740 |
| 88 | Prolonged QT interval (HP:0001657) | 2.01151604 |
| 89 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.99487548 |
| 90 | Bundle branch block (HP:0011710) | 1.96513279 |
| 91 | Increased circulating renin level (HP:0000848) | 1.95769465 |
| 92 | Gait ataxia (HP:0002066) | 1.95262191 |
| 93 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.93316021 |
| 94 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.93316021 |
| 95 | Insomnia (HP:0100785) | 1.92112979 |
| 96 | Exotropia (HP:0000577) | 1.91641535 |
| 97 | Specific learning disability (HP:0001328) | 1.91616865 |
| 98 | Stomatitis (HP:0010280) | 1.88947812 |
| 99 | Ventricular fibrillation (HP:0001663) | 1.88782575 |
| 100 | Abnormality of saccadic eye movements (HP:0000570) | 1.88446370 |
| 101 | Rapidly progressive (HP:0003678) | 1.87465638 |
| 102 | Truncal obesity (HP:0001956) | 1.86114836 |
| 103 | Rigidity (HP:0002063) | 1.85592045 |
| 104 | Apathy (HP:0000741) | 1.83533380 |
| 105 | Psychosis (HP:0000709) | 1.83202324 |
| 106 | Central scotoma (HP:0000603) | 1.82957417 |
| 107 | Protruding tongue (HP:0010808) | 1.82414952 |
| 108 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.81307337 |
| 109 | Hypoplasia of the brainstem (HP:0002365) | 1.81307337 |
| 110 | Akinesia (HP:0002304) | 1.81019017 |
| 111 | Thyroid carcinoma (HP:0002890) | 1.80607539 |
| 112 | Frequent falls (HP:0002359) | 1.78379576 |
| 113 | Abnormality of T cell number (HP:0011839) | 1.77931450 |
| 114 | Lower limb amyotrophy (HP:0007210) | 1.77066325 |
| 115 | Clumsiness (HP:0002312) | 1.76969142 |
| 116 | Incomplete penetrance (HP:0003829) | 1.76887667 |
| 117 | Paraplegia (HP:0010550) | 1.75133282 |
| 118 | Menstrual irregularities (HP:0000858) | 1.72141580 |
| 119 | Renal cortical cysts (HP:0000803) | 1.70827659 |
| 120 | Spastic paraplegia (HP:0001258) | 1.67578243 |
| 121 | Limb ataxia (HP:0002070) | 1.66711885 |
| 122 | Abnormality of the renal cortex (HP:0011035) | 1.65507156 |
| 123 | Short chin (HP:0000331) | 1.64655547 |
| 124 | Abnormality of the periventricular white matter (HP:0002518) | 1.64429561 |
| 125 | Syncope (HP:0001279) | 1.63464528 |
| 126 | Chronic hepatic failure (HP:0100626) | 1.62316577 |
| 127 | Gait imbalance (HP:0002141) | 1.62128076 |
| 128 | Abnormal EKG (HP:0003115) | 1.61811485 |
| 129 | Hypothermia (HP:0002045) | 1.60623178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.26869279 |
| 2 | MAP3K9 | 3.99924851 |
| 3 | EPHA4 | 3.66110564 |
| 4 | FRK | 3.63922430 |
| 5 | MARK1 | 3.33073975 |
| 6 | MAP3K4 | 3.22442770 |
| 7 | MINK1 | 2.80127521 |
| 8 | DAPK2 | 2.40541085 |
| 9 | MAP2K7 | 2.34105085 |
| 10 | PAK6 | 2.33555357 |
| 11 | NTRK2 | 2.06922875 |
| 12 | MAP2K4 | 2.04537604 |
| 13 | NTRK1 | 2.00861139 |
| 14 | KSR2 | 1.97554494 |
| 15 | RIPK4 | 1.97390964 |
| 16 | PRKD3 | 1.86299644 |
| 17 | MAP4K2 | 1.81452044 |
| 18 | CAMKK1 | 1.78408840 |
| 19 | AKT3 | 1.74360667 |
| 20 | TXK | 1.67118953 |
| 21 | MAP3K12 | 1.67114400 |
| 22 | KSR1 | 1.61378948 |
| 23 | CDK5 | 1.57178692 |
| 24 | ACVR1B | 1.45554510 |
| 25 | CASK | 1.44896599 |
| 26 | PLK2 | 1.40297794 |
| 27 | DAPK1 | 1.37690061 |
| 28 | PNCK | 1.33437034 |
| 29 | MAP3K2 | 1.32198800 |
| 30 | MAP3K13 | 1.30725504 |
| 31 | UHMK1 | 1.25062078 |
| 32 | SIK2 | 1.24317966 |
| 33 | GRK5 | 1.21652008 |
| 34 | STK38 | 1.19610592 |
| 35 | FES | 1.18613365 |
| 36 | MAPK13 | 1.18008454 |
| 37 | WNK3 | 1.17629009 |
| 38 | PHKG1 | 1.17286431 |
| 39 | PHKG2 | 1.17286431 |
| 40 | ARAF | 1.15872752 |
| 41 | PRKCG | 1.14924276 |
| 42 | CAMK1D | 1.14302032 |
| 43 | SGK494 | 1.12131837 |
| 44 | SGK223 | 1.12131837 |
| 45 | CAMKK2 | 1.11636666 |
| 46 | TYRO3 | 1.09665991 |
| 47 | CDK19 | 1.05732548 |
| 48 | RET | 1.03702615 |
| 49 | ICK | 1.01482526 |
| 50 | SGK2 | 0.97722508 |
| 51 | CAMK1G | 0.94219781 |
| 52 | ERBB3 | 0.94048460 |
| 53 | TNIK | 0.93587062 |
| 54 | PRKCH | 0.92970597 |
| 55 | SGK3 | 0.92364607 |
| 56 | CAMK2A | 0.89852744 |
| 57 | OBSCN | 0.88688588 |
| 58 | PAK3 | 0.86498175 |
| 59 | LATS2 | 0.85799877 |
| 60 | PRPF4B | 0.85735599 |
| 61 | BMPR2 | 0.83300404 |
| 62 | LMTK2 | 0.82494178 |
| 63 | SCYL2 | 0.81347917 |
| 64 | CDK14 | 0.80974233 |
| 65 | BMPR1B | 0.80878369 |
| 66 | CDK18 | 0.80432432 |
| 67 | JAK1 | 0.79466468 |
| 68 | STK11 | 0.79044495 |
| 69 | CSNK1G2 | 0.78624757 |
| 70 | SGK1 | 0.77672539 |
| 71 | CDK15 | 0.77360231 |
| 72 | PTK2B | 0.77285833 |
| 73 | TAOK3 | 0.74908958 |
| 74 | NEK6 | 0.74461463 |
| 75 | PINK1 | 0.73843215 |
| 76 | CAMK1 | 0.73748376 |
| 77 | NLK | 0.70605506 |
| 78 | CAMK2B | 0.69620796 |
| 79 | WNK1 | 0.68558447 |
| 80 | CDK3 | 0.68249061 |
| 81 | PIK3CG | 0.68241259 |
| 82 | BRD4 | 0.67937475 |
| 83 | MARK2 | 0.66436691 |
| 84 | PDK1 | 0.64816357 |
| 85 | RAF1 | 0.63548785 |
| 86 | TRIM28 | 0.63499042 |
| 87 | BLK | 0.63482641 |
| 88 | CDK11A | 0.63084645 |
| 89 | FER | 0.62791820 |
| 90 | PDPK1 | 0.62616733 |
| 91 | TEC | 0.60895831 |
| 92 | TAOK1 | 0.59890314 |
| 93 | OXSR1 | 0.58802121 |
| 94 | MAP3K1 | 0.58711581 |
| 95 | PRKG1 | 0.58494854 |
| 96 | SYK | 0.58018844 |
| 97 | PRKCZ | 0.57814226 |
| 98 | JAK2 | 0.55570577 |
| 99 | FGFR2 | 0.55234852 |
| 100 | DYRK1A | 0.54968802 |
| 101 | RPS6KA3 | 0.53736686 |
| 102 | MAPK10 | 0.52310226 |
| 103 | STK39 | 0.51609947 |
| 104 | FYN | 0.51278455 |
| 105 | ALK | 0.50882037 |
| 106 | MAP2K6 | 0.50722654 |
| 107 | CSNK1G1 | 0.50563511 |
| 108 | MAPK12 | 0.50358071 |
| 109 | PRKCE | 0.50262844 |
| 110 | INSRR | 0.49518260 |
| 111 | FGFR3 | 0.47082578 |
| 112 | BCR | 0.46751887 |
| 113 | MAP3K7 | 0.46202122 |
| 114 | MAP2K1 | 0.45586926 |
| 115 | RPS6KA2 | 0.45516759 |
| 116 | TRPM7 | 0.44517450 |
| 117 | CSNK1D | 0.44489117 |
| 118 | CDC42BPA | 0.42734423 |
| 119 | FGR | 0.42727528 |
| 120 | CAMK2D | 0.41609297 |
| 121 | IRAK2 | 0.39467111 |
| 122 | CSNK1A1L | 0.38944725 |
| 123 | MAP3K6 | 0.38481141 |
| 124 | EIF2AK3 | 0.37874628 |
| 125 | ITK | 0.37662229 |
| 126 | DMPK | 0.37623337 |
| 127 | PKN1 | 0.37432914 |
| 128 | PRKAA1 | 0.36865410 |
| 129 | CAMK4 | 0.36749036 |
| 130 | TNK2 | 0.36426532 |
| 131 | NEK1 | 0.35649159 |
| 132 | PRKCB | 0.34773470 |
| 133 | CAMK2G | 0.34641889 |
| 134 | ROCK2 | 0.33187537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.32353793 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.28160694 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.51703922 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.48993138 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.46765768 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.46713877 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.44333670 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35387649 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.27793547 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.26602849 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.22595964 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.13009093 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.06622269 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.03828687 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83529534 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75481045 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73870402 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.69368268 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62485970 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.62226909 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.54565832 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.54007480 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53593945 |
| 24 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.53384708 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53367140 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.49690196 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48889583 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.48625199 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.48218142 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43201022 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40209020 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.34874933 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26479090 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23850469 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19806945 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19001193 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15842474 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.15640571 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15453173 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14424098 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.13798504 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12346443 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03415171 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03168791 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02521373 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99133718 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.95444842 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.90233495 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87178029 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86298084 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85833337 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85160817 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83326030 |
| 54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83291703 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80180978 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79209926 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79121932 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78825344 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77573489 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75883695 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75746416 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75720614 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75379977 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74555489 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74470223 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71080007 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70881326 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69367729 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68879676 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67575069 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65941072 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63892210 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.63431497 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.63335579 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.62447963 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62088969 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61453934 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61403444 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60043078 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58306724 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57940566 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57268655 |
| 83 | Allograft rejection_Homo sapiens_hsa05330 | 0.56695799 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56639806 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.56499788 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56462823 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52638606 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.50636362 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49938422 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49492410 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49485343 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.49181704 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48718066 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48372774 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48287585 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48210221 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48039912 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47093767 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45143017 |
| 100 | Tuberculosis_Homo sapiens_hsa05152 | 0.44627358 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41296288 |
| 102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41172378 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39913202 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38377072 |
| 105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38322524 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37613373 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37426726 |
| 108 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36686358 |
| 109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36559754 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35393480 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34919328 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34701195 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.34310720 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33688970 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33100360 |
| 116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.32708534 |
| 117 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32118367 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30997313 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30974558 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30426809 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29634973 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28687102 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28323871 |

